UniQure (QURE) shares were 65% lower pre-bell Monday after the company said it believes that the US Food and Drug Administration no longer considers its Huntington's disease therapy data adequate to support a biologics license application.
ClearPoint Neuro (CLPT) stock was down 23% following a 1.9% loss in the previous session.
Alvotech (ALVO) shares were 23% lower, adding to Friday's 2.4% decrease.
NewcelX (NCEL) stock was down 18%, paring Friday's rally.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.